🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Postprandial glucose (PPG) excursions are not only determined by insulin-me...
Status
Completed
Location
Multiple Locations
Start Date
2015-08
Trial ID
NCT02640118
Treatments Being Tested
The current study has two aims: 1. to test the hypothesis that a single do...
Status
Unknown
Location
Tartu University Hospital
Start Date
2023-04-17
Trial ID
NCT05804513
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-05
Trial ID
NCT00688701
Treatments Being Tested
Primary Objective: \- To investigate the effects of two single subcutaneou...
Status
Completed
Location
Investigational Site Number 840005
Start Date
2012-05
Trial ID
NCT01572649
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-06
Trial ID
NCT00712673
Treatments Being Tested
The main objective of the study is to evaluate the effect of lixisenatide (...
Status
Completed
Location
University Hospital of Amiens
Start Date
2018-06-13
Trial ID
NCT03439943
Treatments Being Tested
Primary objective: \- To evaluate the effect of lixisenatide versus placeb...
Status
Completed
Location
Investigational Site Number 840010
Start Date
2013-06
Trial ID
NCT01798706
Treatments Being Tested
The objective of this study is to test whether Lixisenatide (AVE0010) resto...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2009-06
Trial ID
NCT00931372
Treatments Being Tested
The purpose of this study is to evaluate the benefits and risks of lixisena...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00763451
Treatments Being Tested
Glucagon-like-peptide-1 (GLP-1) analogues are a new treatment for type 2 di...
Status
Completed
Location
University of Surrey FHMS Diabetes and Metabolic Medicine
Start Date
2014-01
Trial ID
NCT02049034
Treatments Being Tested